Abstract
In order to fully explore the biology of a complex solid tumor such as prostate cancer, it is desirable to work with patient tissue. Only by working with cells from a tissue can we take into account patient variability and tumor heterogeneity. Cell lines have long been regarded as the workhorse of cancer research and it could be argued that they are of most use when considered within a panel of cell lines, thus taking into account specified mutations and variations in phenotype between different cell lines. However, often very different results are obtained when comparing cell lines to primary cells cultured from tissue. It stands to reason that cells cultured from patient tissue represents a close-to-patient model that should and does produce clinically relevant data. This chapter aims to illustrate the methods of processing, storing and culturing cells from prostate tissue, with a description of potential uses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chaproniere DM, McKeehan WL (1986) Serial culture of single adult human prostatic epithelial cells in serum-free medium containing low calcium and a new growth factor from bovine brain. Cancer Res 46(2):819–824
McKeehan WL, Adams PS, Rosser MP (1984) Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture. Cancer Res 44(5):1998–2010
Frame FM et al (2010) Development and limitations of lentivirus vectors as tools for tracking differentiation in prostate epithelial cells. Exp Cell Res 316(19):3161–3171
Hager S et al (2008) An internal polyadenylation signal substantially increases expression levels of lentivirus-delivered transgenes but has the potential to reduce viral titer in a promoter-dependent manner. Hum Gene Ther 19(8):840–850
Polson ES et al (2013) Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cells. Nat Commun 4:1623
Kroon P et al (2013) JAK-STAT blockade inhibits tumor initiation and clonogenic recovery of prostate cancer stem-like cells. Cancer Res 73(16):5288–5298
Oldridge EE et al (2013) Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXN. Oncogenesis 2:e45
Pellacani D et al (2014) DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation. Cell Death Differ 21(5):761–773
Pellacani D et al (2011) Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer. Mol Cancer 10:94
Swift SL, Burns JE, Maitland NJ (2010) Altered expression of neurotensin receptors is associated with the differentiation state of prostate cancer. Cancer Res 70(1):347–356
Collins AT et al (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65(23):10946–10951
Adamson RE et al (2012) In vitro primary cell culture as a physiologically relevant method for preclinical testing of human oncolytic adenovirus. Hum Gene Ther 23(2):218–230
Birnie R et al (2008) Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biol 9(5):R83
Frame FM et al (2013) HDAC inhibitor confers radiosensitivity to prostate stem-like cells. Br J Cancer 109(12):3023–3033
Rane JK et al (2014) Conserved two-step regulatory mechanism of human epithelial differentiation. Stem Cell Rep 2(2):180–188
Guo C et al (2012) Epcam, CD44, and CD49f distinguish sphere-forming human prostate basal cells from a subpopulation with predominant tubule initiation capability. PLoS One 7(4):e34219
Williamson SC et al (2012) Human alpha(2)beta(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor. PLoS One 7(11):e48944
Jeter CR et al (2011) NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 30(36):3833–3845
van den Hoogen C et al (2010) High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res 70(12):5163–5173
Garraway IP et al (2010) Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate 70(5):491–501
Buhler P et al (2010) Primary prostate cancer cultures are models for androgen-independent transit amplifying cells. Oncol Rep 23(2):465–470
Jiang M et al (2010) Functional remodeling of benign human prostatic tissues in vivo by spontaneously immortalized progenitor and intermediate cells. Stem Cells 28(2):344–356
Guzman-Ramirez N et al (2009) In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue. Prostate 69(15):1683–1693
Attard G et al (2009) A novel, spontaneously immortalized, human prostate cancer cell line, Bob, offers a unique model for pre-clinical prostate cancer studies. Prostate 69(14):1507–1520
Goldstein AS et al (2008) Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci U S A 105(52):20882–20887
Brown MD et al (2007) Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations. Prostate 67(13):1384–1396
Heer R et al (2006) KGF suppresses alpha2beta1 integrin function and promotes differentiation of the transient amplifying population in human prostatic epithelium. J Cell Sci 119(Pt 7):1416–1424
Shepherd CJ et al (2008) Expression profiling of CD133+ and CD133- epithelial cells from human prostate. Prostate 68(9):1007–1024
Niranjan B et al (2013) Primary culture and propagation of human prostate epithelial cells. Methods Mol Biol 945:365–382
Blow NS (2011) Right cell, wrong cell. BioTechniques 51(2):75
Nardone RM (2008) Curbing rampant cross-contamination and misidentification of cell lines. BioTechniques 45(3):221–227
Phuchareon J et al (2009) Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2. PLoS One 4(6):e6040
Barallon R et al (2010) Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues. In vitro cellular & developmental biology. Animal 46(9):727–732
Schenk E et al (2014) Preclinical safety assessment of Ad[I/PPT-E1A], a novel oncolytic adenovirus for prostate cancer. Human gene therapy. Clin Dev 25(1):7–15
Ulukaya E et al (2013) Differential cytotoxic activity of a novel palladium-based compound on prostate cell lines, primary prostate epithelial cells and prostate stem cells. PLoS One 8(5):e64278
Niu J, Zhang B, Chen H (2014) Applications of TALENs and CRISPR/Cas9 in human cells and their potentials for gene therapy. Mol Biotechnol 56(8):681–688
Maitland NJ et al (2010) Prostate cancer stem cells: do they have a basal or luminal phenotype? Horm Cancer 2(1):47–61
Hudson DL et al (2001) Epithelial cell differentiation pathways in the human prostate: identification of intermediate phenotypes by keratin expression. J Histochem Cytochem 49(2):271–278
Hudson DL et al (2000) Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells. Lab Investig 80(8):1243–1250
Collins AT et al (2001) Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J Cell Sci 114(Pt 21):3865–3872
Richardson GD et al (2004) CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117(Pt 16):3539–3545
Robinson EJ, Neal DE, Collins AT (1998) Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate 37(3):149–160
Rane JK, Pellacani D, Maitland NJ (2012) Advanced prostate cancer--a case for adjuvant differentiation therapy. Nat Rev Urol 9(10):595–602
Nagle RB et al (1987) Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. Cancer Res 47(1):281–286
Humphrey PA (2007) Diagnosis of adenocarcinoma in prostate needle biopsy tissue. J Clin Pathol 60(1):35–42
El-Alfy M et al (2000) Unique features of the basal cells of human prostate epithelium. Microsc Res Tech 51(5):436–446
Chambers KF et al (2011) Stroma regulates increased epithelial lateral cell adhesion in 3D culture: a role for actin/cadherin dynamics. PLoS One 6(4):e18796
Lang SH et al (2010) Modeling the prostate stem cell niche: an evaluation of stem cell survival and expansion in vitro. Stem Cells Dev 19(4):537–546
Lang SH et al (2001) Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures. Br J Cancer 85(4):590–599
Lang SH et al (2006) Differentiation of prostate epithelial cell cultures by Matrigel/stromal cell glandular reconstruction. In vitro cellular & developmental biology. Animal 42(8–9):273–280
Lang SH et al (2001) Experimental prostate epithelial morphogenesis in response to stroma and three-dimensional Matrigel culture. Cell Growth Differ 12(12):631–640
Pearson JF et al (2009) Polarized fluid movement and not cell death, creates luminal spaces in adult prostate epithelium. Cell Death Differ 16(3):475–482
Acknowledgements
This work was supported by a Yorkshire Cancer Research Core Grant (Y257PA). Photo credits to: Paula Kroon, Rachel Adamson, Shona Lang, Paul Berry, Stephanie Swift.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Frame, F.M., Pellacani, D., Collins, A.T., Maitland, N.J. (2016). Harvesting Human Prostate Tissue Material and Culturing Primary Prostate Epithelial Cells. In: McEwan, PhD, I. (eds) The Nuclear Receptor Superfamily. Methods in Molecular Biology, vol 1443. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3724-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3724-0_12
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3722-6
Online ISBN: 978-1-4939-3724-0
eBook Packages: Springer Protocols